MARKET

ILMN

ILMN

Illumina
NASDAQ

Real-time Quotes | Nasdaq Last Sale

303.98
-1.65
-0.54%
After Hours: 304.65 +0.67 +0.22% 17:33 11/25 EST
OPEN
309.24
PREV CLOSE
305.63
HIGH
309.40
LOW
301.73
VOLUME
541.25K
TURNOVER
--
52 WEEK HIGH
404.20
52 WEEK LOW
196.78
MARKET CAP
44.38B
P/E (TTM)
70.69
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
The CDC is expected to shorten Covid quarantine time, something most everyone seems to agree on
"I mean, frankly we probably should have done this sooner," Dr. Scott Gottlieb, the former U.S. Food and Drug Administration commissioner, told CNBC.
CNBC.com · 22h ago
Precision Medicine is Coming. What That Means for Patients and Investors.
Dr. Charles Kennedy, CEO of Blue Ox Healthcare Partners, answers Barron’s readers’ questions on health-care innovation, delivery, and investing.
Barrons.com · 1d ago
Here's Why You Should Hold on to Illumina (ILMN) Stock for Now
Investors continue to be optimistic about Illumina (ILMN), backed by its focus on partnerships and worldwide expansion to drive growth.
Zacks · 1d ago
U.S. reports record 187,833 new Covid cases as CDC warns against Thanksgiving travel
"We're alarmed," Dr. Henry Walke, the CDC's Covid-19 incident manager, said Thursday as the agency advised against traveling during the Thanksgiving period.
CNBC.com · 5d ago
Dr. Scott Gottlieb: Schools need to be 'the last thing' shut down due to rising Covid cases
"Some of these jurisdictions including New York City have it backwards where they close the schools and leave other things open," Dr. Scott Gottlieb told CNBC.
CNBC.com · 6d ago
Dr. Scott Gottlieb urges Covid stimulus, sacrifices: 'This may be the last time we have to do it'
"We need to think about what temporary sacrifices we're willing to make, including economically," Dr. Scott Gottlieb told CNBC on Wednesday.
CNBC.com · 11/18 14:04
Corvex adds Illumina, sheds IAA, buys more Exelon
Corvex's current portfolio value is ~$1.7B, according to its latest 13 filing.Notable new position include in First Energy (FE), Aecom (ACM), Twitter (TWTR), Zendesk (ZEN), Walt Disney (DIS), Illumina (ILMN).Notably
Seekingalpha · 11/17 19:34
Moderna trial investigator says vaccinating U.S. against Covid will be a 'major effort'
"If we can do that we will be back to a normal state by the end of next year," Dr. Carlos del Rio of Emory University told CNBC.
CNBC.com · 11/16 20:44
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ILMN. Analyze the recent business situations of Illumina through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 19 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ILMN stock price target is 296.47 with a high estimate of 355.00 and a low estimate of 250.00.
EPS
Institutional Holdings
Institutions: 1.23K
Institutional Holdings: 140.11M
% Owned: 95.96%
Shares Outstanding: 146.00M
TypeInstitutionsShares
Increased
358
9.92M
New
176
1.46M
Decreased
295
13.01M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.24%
Healthcare Equipment & Supplies
-0.25%
Key Executives
Chairman/Director
Jay Flatley
President/Chief Executive Officer/Director
Francis deSouza
Chief Financial Officer/Senior Vice President
Sam Samad
Senior Vice President/General Counsel/Secretary
Charles Dadswell
Senior Vice President
Phillip Febbo
Senior Vice President
Joydeep Goswami
Senior Vice President
Aimee Hoyt
Senior Vice President
Mostafa Ronaghi
Senior Vice President
Robert Ragusa
Senior Vice President
Mark Van Oene
Chief Technology Officer
Alex Aravanis
Lead Director/Independent Director
John Thompson
Independent Director
Frances Arnold
Independent Director
Caroline Dorsa
Independent Director
Robert Epstein
Independent Director
Scott Gottlieb
Independent Director
Gary Guthart
Independent Director
Philip Schiller
Independent Director
Susan Siegel
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About ILMN
Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations. Core Illumina's products and services serve customers in the research, clinical and applied markets, and enable the adoption of a range of genomic solutions. The Company's portfolio of integrated systems, consumables and analysis tools addresses the range of genomic complexity, price points, and throughput, enabling customers to select the solution for their research or clinical challenge. The Company provides reproductive-health solutions, including noninvasive prenatal testing (NIPT), preimplantation genetic screening and diagnosis, and neonatal and genetic health testing.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Illumina, Inc. stock information, including NASDAQ:ILMN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ILMN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ILMN stock methods without spending real money on the virtual paper trading platform.